[go: up one dir, main page]

NO179103C - Fremgangsmåte for fremstilling av antiinflammatoriske 1-heteroaryl-3-acyl-2-oksindoler - Google Patents

Fremgangsmåte for fremstilling av antiinflammatoriske 1-heteroaryl-3-acyl-2-oksindoler

Info

Publication number
NO179103C
NO179103C NO912694A NO912694A NO179103C NO 179103 C NO179103 C NO 179103C NO 912694 A NO912694 A NO 912694A NO 912694 A NO912694 A NO 912694A NO 179103 C NO179103 C NO 179103C
Authority
NO
Norway
Prior art keywords
oxindoles
heteroaryl
acyl
alkyl
formula
Prior art date
Application number
NO912694A
Other languages
English (en)
Norwegian (no)
Other versions
NO912694D0 (no
NO179103B (no
NO912694L (no
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO912694D0 publication Critical patent/NO912694D0/no
Publication of NO912694L publication Critical patent/NO912694L/no
Publication of NO179103B publication Critical patent/NO179103B/no
Publication of NO179103C publication Critical patent/NO179103C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO912694A 1989-01-10 1991-07-09 Fremgangsmåte for fremstilling av antiinflammatoriske 1-heteroaryl-3-acyl-2-oksindoler NO179103C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000079 WO1990008145A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles

Publications (4)

Publication Number Publication Date
NO912694D0 NO912694D0 (no) 1991-07-09
NO912694L NO912694L (no) 1991-07-09
NO179103B NO179103B (no) 1996-04-29
NO179103C true NO179103C (no) 1996-08-07

Family

ID=22214772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912694A NO179103C (no) 1989-01-10 1991-07-09 Fremgangsmåte for fremstilling av antiinflammatoriske 1-heteroaryl-3-acyl-2-oksindoler

Country Status (18)

Country Link
EP (1) EP0378358B1 (he)
JP (1) JPH0692400B2 (he)
KR (1) KR920006785B1 (he)
AT (1) ATE96793T1 (he)
AU (1) AU616336B2 (he)
CA (1) CA2007655C (he)
DE (1) DE69004272T2 (he)
DK (1) DK0378358T3 (he)
ES (1) ES2060007T3 (he)
FI (1) FI92827C (he)
HU (1) HU215112B (he)
IE (1) IE62143B1 (he)
IL (1) IL92962A (he)
NO (1) NO179103C (he)
NZ (1) NZ232039A (he)
PT (1) PT92800B (he)
WO (1) WO1990008145A1 (he)
ZA (1) ZA90139B (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
CN108456205B (zh) * 2018-05-21 2021-06-04 深圳市众康动保科技有限公司 一种3,3二取代羟基吲哚化合物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
IN163263B (he) * 1984-02-07 1988-08-27 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4695571A (en) * 1984-08-24 1987-09-22 Pfizer Inc. Tricyclic oxindole antiinflammatory agents
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
KR900011762A (ko) 1990-08-02
CA2007655A1 (en) 1991-07-12
IE900075L (en) 1990-07-10
ZA90139B (en) 1991-08-28
DE69004272T2 (de) 1994-02-24
EP0378358B1 (en) 1993-11-03
IL92962A (he) 1995-01-24
JPH0692400B2 (ja) 1994-11-16
FI92827C (fi) 1995-01-10
ATE96793T1 (de) 1993-11-15
ES2060007T3 (es) 1994-11-16
HU215112B (hu) 1998-12-28
FI913324A0 (fi) 1991-07-09
NO912694D0 (no) 1991-07-09
FI92827B (fi) 1994-09-30
EP0378358A1 (en) 1990-07-18
NZ232039A (en) 1991-07-26
JPH02270868A (ja) 1990-11-05
AU616336B2 (en) 1991-10-24
DK0378358T3 (da) 1993-12-06
NO179103B (no) 1996-04-29
PT92800A (pt) 1990-07-31
HUT62292A (en) 1993-04-28
CA2007655C (en) 1996-10-22
PT92800B (pt) 1995-12-29
WO1990008145A1 (en) 1990-07-26
DE69004272D1 (de) 1993-12-09
KR920006785B1 (ko) 1992-08-17
AU4781690A (en) 1990-07-19
IE62143B1 (en) 1994-12-14
NO912694L (no) 1991-07-09

Similar Documents

Publication Publication Date Title
NO20011721L (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5- reseptoren
MX9805291A (es) Derivados de feniltiazol con propiedades anti-virus de herpes.
ATE488500T1 (de) 2-oxo-1-pyrrolidin-derivate, verfahren zu ihrer herstellung und ihre verwendung.
FI874395A (fi) Hydraulisk cylinderanordning foer avkaenning och reglering av avstaondet mellan pressbord.
DE60026404D1 (de) Verfahren zur Herstellung von Benzothiophen-Derivaten
FI954994A (fi) 3-(het)aryylikarboksyylihappojohdannaiset, menetelmä ja välituotteet niiden valmistamiseksi
AR002041A1 (es) Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.
ATE229526T1 (de) Pyranone, verfahren zu ihrer herstellung und verwendung
NO179103C (no) Fremgangsmåte for fremstilling av antiinflammatoriske 1-heteroaryl-3-acyl-2-oksindoler
JPS5439040A (en) Novel 2-hydroxybenzamide derivatives and bactericides for the soil
NO161618C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater.
BR9612196A (pt) Tiazolinas substituidas
KR910002818A (ko) 4,5,6,7-사치환된 벤즈옥사졸론
NO178193C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-heteroaryloksindol-3-karboksamider
EP0365194A3 (en) Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
IE42068L (en) Naphthopyran and benzodipyran 2-carboxylic acids
IE38064L (en) 2-amino-4h-pyran derivatives.
DE60102695D1 (de) Neue verwendung von citreamicinen
GB9512005D0 (en) Slip casting
NO934399L (no) Tioesterderivater av 3'-O-propargyl-trifluortymidin, fremgangsmåte for fremstilling samt anvendelse av slike
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
FI901723A0 (fi) Anordning foer upprullning och avrullning av staengselnaet.
TW366344B (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same
KR927003511A (ko) 5-리폭시게나제 억제제로서의 2-아릴메틸-1-나프톨 유도체의 에스테르

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees